PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.02%
Revenue growth similar to RUN's 12.90%. Walter Schloss would see if both companies share industry tailwinds.
19.50%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
47.10%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
47.10%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
18.20%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
14.29%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.08%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-4.47%
Share reduction while RUN is at 1.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.70%
Reduced diluted shares while RUN is at 1.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-740.28%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-250.83%
Negative FCF growth while RUN is at 156.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1309.36%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1309.36%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
1309.36%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-2660.50%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-2660.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2660.50%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
220.80%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
220.80%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
220.80%
3Y net income/share CAGR similar to RUN's 220.80%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.44%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-12.62%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.21%
Asset growth at 50-75% of RUN's 4.18%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
7.35%
50-75% of RUN's 11.80%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
1.10%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.